Bacterial production

Research into elastin, its properties, and the fiber formation was for a considerable period of time hindered due to its insolubihty. However, discovery of the soluble tropoelastin precursor made new investigations possible. The tropoelastin protein can be isolated from copper-deficient animals. However, this is a very animal-unfriendly and low yielding process [2]. Therefore, it is preferred to obtain tropoelastin from overexpression in microbial hosts such as Escherichia coli (E. coli). Most studies are thus based on tropoelastin obtained via bacterial production. 

There are a number of disorders, including cancer and shock, in which the concentrations of plasminogen activators increase. In addition, the antiplasmin activities contributed by tti-antitrypsin and a2-antiplas-min may be impaired in diseases such as cirrhosis. Since certain bacterial products, such as streptokinase, are capable of activating plasminogen, they may be responsible for the diffuse hemotthage sometimes observed in patients with disseminated bacterial infections. 

H. Christensen, R. Rpnn, F. Ekelund, and S. Christensen, Bacterial production determined by [ HIthymidine incorporation in field rhizospheres as evaluated by comparison to rhizodeposition. Soil Biol. Biochem. 27 93 (1995). 

Bacterial products such as lipopolysaccharides (endotoxins) and cytokines (IL-2) are able to activate the contact system in vitro and in vivo (D9, H4, H7, M41). Immediately after severe trauma or after surgical intervention and particularly during sepsis, a reduction of plasma contact system proteins has been found (C10, K1, N9). Gel filtration studies of plasma demonstrated that plasma PK after activation becomes complexed with a2-M and Cl-Inh (W4). These complexes are rapidly eliminated from the circulation in vivo. In experimental studies in which pulmonary insufficiency was induced in dogs, a significant reduction of plasma kallikrein inhibitors was observed together with reduced HMK. Analysis of the relation be-... 

The main question is whether synthesis of PHA in plants can succeed in bringing the cost of the polymer down to the range of 0.5 -1 US /kg. Bacterial production of PHA typically relies on a carbon source, such as sucrose or glucose, which is produced from photosynthesis and extracted from plants. Synthesis of PHA directly in plants would, therefore, represent a saving in terms of the number of intermediary steps linking C02 fixation to PHA production. Furthermore, starch is one of the cheapest plant commodity product on the market, at about 0.25 US /kg [86]. It is, thus, likely that the production cost of PHA in plants will be substantially cheaper than bacterial fermentation. The final cost of producing PHA in plants will depend on a number of factors. 

Recent experimental data, coming particularly from animal models of IBD, are consistent with the hypothesis that gut flora and bacterial products are implicated in the initiation and/or perpetuation of chronic intestinal inflammation. Purified bacterial products can initiate and perpetuate experimental colitis [1,2]. 

The leading hypothesis for the development of chronic intestinal inflammation is that an abnormal immune response to normal flora might be crucial. This loss of tolerance might be due to a lack of regulatory mediators or cells, or a breakdown in barrier function which makes possible the access of inflammatory bacterial products to the local immune system, thereby overwhelming the normal regulation [3], These possibilities were supported by... 

IHC techniques provide important tools for the localization of specific antigens within individual cells. In CL IHC the probes used are highly specific antibodies that bind to antigens such as proteins, enzymes, and viral or bacterial products. The bound specific antibody is revealed indirectly by species-specific or class-specific secondary antibodies conjugated to CL enzymes. 

Phagocytosis and encapsulation, in which pathogens are sequestered within several layers of cells, are the predominant cellular immune responses. Genetic and molecular studies have shown that bacterial products are recognized24 and transduced by host cells25 26 by similar pattern recognition receptors and signal transduction pathways in both vertebrates and invertebrates. 

Division of Allergenic Products Parasitology Thomas Hoffman, M.D., Acting Division of Bacterial Products Drusilla Burns, Ph.D., Acting Division of Viral Products Peter Patriarca, M.D. 

Pathogens known to stimulate CSF production include Salmonella typhi-murium, Mycobacterium lepraemurium, Brucella abortus and Schistosoma mansonii. Additionally, non-viable bacteria or bacterial products, such as Nocardia rubra cell-wall fragments, muramyl peptides and bacterial endotoxins, can also induce CSF production. 

Whereas standard proteases use serine, cysteine, aspartate, or metals to cleave peptide bonds, the proteasome employs an unusual catalytic mechanism. N-terminal threonine residues are generated by self-removal of short peptide extensions from the active yS-subunits and act as nucleophiles during peptide-bond hydrolysis [23]. Given its unusual catalytic mechanism, it is not surprising that there are highly specific inhibitors of the proteasome. The fungal metabolite lactacystin and the bacterial product epoxomicin covalently modify the active-site threonines and in-... 

In monocytes stimulated with Toll-like receptor-triggering bacterial products, histamine inhibits the production of proinflammatory IL-1-like activity, TNF-a, IL-12 and IL-18, but enhances IL-10 secretion, through HR2 stimulation [26, 69]. Histamine also downregulates CD 14 expression via Hj receptors on human monocytes [70]. The inhibitory effect of histamine via Hj receptor appears through the regulation of ICAM-1 and B7.1 expression, leading to the reduction of innate immune response stimulated by LPS [71]. 

Thuesen EV, Kogure K. (1989) Bacterial production of tetrodotoxin in four species of Chaetognatha. Biol Bull 176 191-194. 

Yasumoto, T., Yasumara, D., Yotsu, M., etal. (1986). Bacterial production of tetrodotoxin and anhydrotetrodotoxin. Agricultural and Biobgical Chemistry 50,793-795. 

---